Thursday, June 18, 2020 4:40:09 PM
We have a drug that is better performing for CC than Bellus yet we are playing T ball and we gotta watch them play triple A.
Hard data for all of the pharma world to see may be our only exit strategy and to get out of this league of losers lol - can we do it?Absolutely I think we can. Like Eagle said it may take a little more time and patience on our end.
This may be Mr Mal's final chance to shuffle his pieces around the chess board before real eyes start taking notice of Algernon. "Pre trial Algernon" era is coming to a close. Soon we will be "Clinical Trial Algernon". Until we morph into "Data Algernon" - by then flipping may very well be a thing of the past. KM would
be super rich and have more than enough to fund his other endeavours and shuffle around BRC. And Algernon would hopefully be playing Major League Baseball by then.
To KM Algernon will be like an ex girlfriend he treated like shit for years. Now she's breaking free flourishing and living her best life and even though its difficult to see her move on. You're deep down genuinely happy for her.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM